Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000414410 | SCV000490688 | pathogenic | not provided | 2023-06-27 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Also known as c.468delG; This variant is associated with the following publications: (PMID: 11479730, 20132240, 37337769, 36140798) |
Labcorp Genetics |
RCV001215069 | SCV001386790 | pathogenic | Aniridia 1; Irido-corneo-trabecular dysgenesis | 2019-06-18 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in PAX6 are known to be pathogenic (PMID: 12634864). This variant has been observed in individuals affected with anirdia (PMID: 11479730, 21423868). This variant is also known as 468delG in the literature. ClinVar contains an entry for this variant (Variation ID: 372438). This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Ala37Profs*17) in the PAX6 gene. It is expected to result in an absent or disrupted protein product. |